Skip to main content

Month: May 2021

Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2021

BANNOCKBURN, Ill., May 06, 2021 (GLOBE NEWSWIRE) — Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2021. First Quarter 2021 Financial HighlightsNet revenue of $759.2 million, up 7.6% compared to $705.4 million in the first quarter of 2020 Gross profit of $165.5 million, or 21.8% of net revenue, up 4.7% compared to $158.0 million, or 22.4% of revenue, in the first quarter of 2020 Net loss of $2.9 million, or $0.02 loss per share, compared to net loss of $19.9 million, or $0.11 loss per share, in the first quarter of 2020 Adjusted EBITDA of $52.2 million, up 30.0% compared to $40.2 million in the first quarter of 2020 Cash flow from operations...

Continue reading

Atea Pharmaceuticals to Host First Quarter Financial Results Conference Call on May 13, 2021

BOSTON, May 06, 2021 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company, today announced that it will host a live conference call and audio webcast on Thursday, May 13, 2021 at 4:30 p.m. ET to report financial results for the first quarter ended March 31, 2021, and to provide a corporate update. To access the live conference call, please dial (833) 301-1150 (domestic) or (914) 987-7391 (international) at least five minutes prior to the start time, and refer to conference ID 8609279. A live audio webcast of the call and accompanying slide presentation will be available in the Investors’ Events & Presentations section of the Company’s website, www.ateapharma.com. An archived webcast will be available on the Atea website approximately two hours after the event. About...

Continue reading

Vonage Reports First Quarter 2021 Financial Results

First Quarter 2021 Highlights:Consolidated Revenues of $333 million Vonage Communications Platform (VCP) Revenues of $255 millionVCP Service Revenues increased 23% API Revenues Increased 47% Unified Communications & Contact Center Service Revenues Increased 4%Net Loss of $376 thousand and Adjusted EBITDA of $48 millionHOLMDEL, N.J., May 06, 2021 (GLOBE NEWSWIRE) — Vonage Holdings Corp. (Nasdaq: VG), a global leader in cloud communications helping businesses accelerate their digital transformation, today announced results for the quarter ended March 31, 2021. “We had a strong first quarter, demonstrating improving execution across our business,” said Rory Read, Chief Executive Officer. “VCP service revenues increased 23% year over year. API revenues grew 47%, highlighted by high-value APIs, which grew 112%, with continued...

Continue reading

Lifetime Brands, Inc. Reports First Quarter 2021 Financial Results

GARDEN CITY, N.Y., May 06, 2021 (GLOBE NEWSWIRE) — Lifetime Brands, Inc. (NasdaqGS: LCUT), a leading global designer, developer and marketer of a broad range of branded consumer products used in the home, today reported its financial results for the quarter ended March 31, 2021. Robert Kay, Lifetime’s Chief Executive Officer, commented, “Lifetime Brands is off to an excellent start in 2021 with top line growth of 34.9% driving net income of $3.1 million and year-over-year growth in Adjusted EBITDA of 418% or $13.6 million. This represents the seventh consecutive quarter of year-over-year growth from our core US business, which continues to lead our overall business. Our strong results this quarter demonstrate Lifetime’s ability to consistently outperform across our categories in the many channels which we sell our products. We...

Continue reading

Liquidia Corporation to Report First Quarter 2021 Financial Results on May 13, 2021

MORRISVILLE, N.C., May 06, 2021 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) announced today that it will report its first quarter 2021 financial results on Thursday, May 13, 2021. The company will host a webcast and conference call at 8:30 a.m. Eastern Daylight Time to discuss financial results and provide a corporate update. The live call may be accessed by dialing 1-877-707-8711 (domestic) or 1-857-270-6219 (international) and entering the conference code: 2007727. A webcast of the call will be available and archived on Liquidia’s website at https://liquidia.com/index.php/investors/events-and-presentations. About Liquidia CorporationLiquidia Corporation is a biopharmaceutical company focused on the development and commercialization of products in pulmonary hypertension and other applications of its PRINT® Technology....

Continue reading

BC Craft Supply Retains Jordache Commodities Ltd. to Manage and Develop Medcann Facility

VANCOUVER, British Columbia, May 06, 2021 (GLOBE NEWSWIRE) — BC Craft Supply Co. Ltd. (the “Company” or “BC Craft”) (CSE: CRFT) (OTC:CRFTF) (FSE:ZZD1) is pleased to announce that it has entered into an advisory and development agreement (the “Advisory and Development Agreement“) with Jordache Commodities Ltd. (the “Consultant” or “Jordache Commodities”) dated May 5, 2021 to manage and develop the Company’s Medcann facility located in Chemainus, British Columbia (the “Consulting Agreement”). Terms of the Advisory and Development Agreement In connection with the Advisory and Development Agreement, the Consultant will finance up to $2 million for the development of the Medcann facility (the “Advance”).   Under the terms of the Advisory and Development Agreement, the Consultant will manage the reconstruction of the Medcann...

Continue reading

CV Sciences, Inc. to Announce First Quarter 2021 Results on May 13, 2021

SAN DIEGO, May 06, 2021 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced that it will release financial results for the first quarter ended March 31, 2021, after the stock market closes on Thursday, May 13, 2021. The Company will hold a conference call with the investment community at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) that same day. The webcast of the conference call will be available on the Investor Relations section of the Company’s website at https://ir.cvsciences.com/news-events and at http://public.viavid.com/index.php?id=144697. The webcast will be archived for approximately 30 days. Investors interested in participating in the live call can also dial (877) 407-0784...

Continue reading

The Simply Good Foods Company to Participate in the Goldman Sachs Global Staples Forum

DENVER, May 06, 2021 (GLOBE NEWSWIRE) — The Simply Good Foods Company (NASDAQ:SMPL) (“Simply Good Foods” or the “Company”), a developer, marketer and seller of branded nutritional foods and snacking products, today announced that members of the executive management team will participate in a virtual fireside chat at the Goldman Sachs Global Staples Forum on Tuesday, May 18, 2021 at 10:30 a.m. ET. The live audio webcast will be available at http://www.thesimplygoodfoodscompany.com within the Recent Events section of the Company’s website and be archived for 30 days. About The Simply Good Foods CompanyThe Simply Good Foods Company (Nasdaq: SMPL), headquartered in Denver, Colorado, is a highly-focused food company with a product portfolio consisting primarily of nutrition bars, ready-to-drink shakes, sweet and salty snacks and confectionery...

Continue reading

Amicus Therapeutics Appoints Sébastien Martel as Senior Vice President of Strategy and Business Development

Most Recently Served as Global Head of Rare Diseases at Sanofi Genzyme Brings Deep Expertise in Corporate Strategy, Business Development and Commercialization PHILADELPHIA, May 06, 2021 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced the appointment of Sébastien Martel as Senior Vice President of Strategy and Business Development. Mr. Martel will lead the Company’s corporate strategy and business and corporate development endeavors. He will be a member of the Amicus senior leadership team. Mr. Martel brings 25 years of diversified pharmaceutical and biotechnology expertise to Amicus, with extensive experience in rare disease, most recently as Senior Vice President, Global Head of Rare Diseases at Sanofi. Mr. Martel has played a key role in managing the launch and growth of several products across therapeutic...

Continue reading

Builders FirstSource Reports Record First Quarter 2021 Results

BUILDERS FIRSTSOURCE, INC. AND SUBSIDIARIESCombined Financial DataBUILDERS FIRSTSOURCE, INC. AND SUBSIDIARIESCondensed Consolidated Statement of OperationsBUILDERS FIRSTSOURCE, INC. AND SUBSIDIARIESCondensed Consolidated Balance SheetBUILDERS FIRSTSOURCE, INC. AND SUBSIDIARIESCondensed Consolidated Statement of Cash FlowsBUILDERS FIRSTSOURCE, INC. AND SUBSIDIARIESReconciliation of Adjusted Non-GAAP Financial Measures to their GAAP EquivalentsBUILDERS FIRSTSOURCE, INC. AND SUBSIDIARIESFinancial DataBUILDERS FIRSTSOURCE, INC. AND SUBSIDIARIESInterest ReconciliationBUILDERS FIRSTSOURCE, INC. AND SUBSIDIARIESSales by Product CategoryBUILDERS FIRSTSOURCE, INC. AND SUBSIDIARIESCombined Financial...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.